Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory AnginaSANTA CLARA, Calif., April 08, 2024 (GLOBE NEWSWIRE) Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today announced that investigators presented six-month data from the full population of the REDUCER-I study, alongside interim long-term follow-up results
Review Article By Misinformation Spreaders Misleads About mRNA COVID-19 Vaccines factcheck.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from factcheck.org Daily Mail and Mail on Sunday newspapers.
Surgery does not result in better outcomes for pituitary apoplexy medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.